Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens

被引：37
|
作者：
Bonomo, Robert A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构：
[1] Vet Affairs Med Ctr, Med Serv, Louis Stokes Cleveland Dept, 10701 East Blvd, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA
[6] Case Western Reserve Univ, Dept Prote & Bioinformat, Cleveland, OH 44106 USA
[7] CWRU Cleveland VAMC Case VA CARES, Cleveland, OH USA
来源：
CLINICAL INFECTIOUS DISEASES | 2019年 / 69卷
关键词：
cefiderocol; cephalosporin; carbapenem-resistant Enterobacteriaceae; nonfermenting gram-negative bacteria; siderophore; GRAM-NEGATIVE PATHOGENS; LACTAMASE INHIBITOR; MULTIDRUG-RESISTANT; BACTERIA;
D O I：
10.1093/cid/ciz823
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Cefiderocol, a novel siderophore cephalosporin in late-stage clinical development, utilizes a "Trojan horse" active transport mechanism to enter bacteria and has proven in vitro activity against carbapenem-resistant gram-negative pathogens, including those with major carbapenem-resistance mechanisms, and stability against all carbapenemases.
引用
收藏
页码：519 / 520
页数：2
相关论文
共 50 条
  • [21] Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogens
    Jorda, Anselm
    Zeitlinger, Markus
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (07) : 777 - 791
  • [22] Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects
    Katsube, Takayuki
    Saisho, Yutaka
    Shimada, Jingoro
    Furuie, Hidetoshi
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (07) : 1971 - 1974
  • [23] In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium
    Oueslati, Saoussen
    Bogaerts, Pierre
    Dortet, Laurent
    Bernabeu, Sandrine
    Ben Lakhal, Hend
    Longshaw, Christopher
    Glupczynski, Youri
    Naas, Thierry
    ANTIBIOTICS-BASEL, 2022, 11 (10):
  • [24] Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections
    Shields, Ryan K.
    Dorazio, Ava J.
    Tiseo, Giusy
    Squires, Kevin M.
    Leonildi, Alessandro
    Giordano, Cesira
    Kline, Ellen G.
    Barnini, Simona
    Iovleva, Alina
    Griffith, Marissa P.
    Van Tyne, Daria
    Doi, Yohei
    Falcone, Marco
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (05):
  • [25] In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA
    Findlay, Jacqueline
    Bianco, Gabriele
    Boattini, Matteo
    Nordmann, Patrice
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (04) : 928 - 930
  • [26] Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii
    Karruli, Arta
    Migliaccio, Antonella
    Pournaras, Spyros
    Durante-Mangoni, Emanuele
    Zarrilli, Raffaele
    ANTIBIOTICS-BASEL, 2023, 12 (12):
  • [27] In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
    Malisova, Lucia
    Vrbova, Iveta
    Pomorska, Katarina
    Jakubu, Vladislav
    Zemlickova, Helena
    MICROBIAL DRUG RESISTANCE, 2023, 29 (10) : 485 - 491
  • [28] CHARACTERIZATION OF CARBAPENEM-RESISTANT BUT CEPHALOSPORIN-SUSCEPTIBLE PSEUDOMONAS AERUGINOSA
    Khalili, Younes
    Yekani, Mina
    Goli, Hamid Reza
    Memar, Mohammad Yousef
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2019, 66 (04) : 529 - 540
  • [29] Pattern of cephalosporin and carbapenem-resistant Pseudomonas aeruginosa: a retrospective analysis
    Albahrani, Salma
    Alqazih, Thikrayat Qazih
    Aseeri, Ali Ahmad
    Al Argan, Reem
    Alkhafaji, Dania
    Alrqyai, Nora Abdullah
    Alanazi, Sami Mohamed
    Aldakheel, Dima Saleh
    Ghazwani, Qassim Hassan
    Jalalah, Salah Saeed
    Alshuaibi, Anwar Khalid
    Hazzazi, Hanadi Ali
    Al-Tawfiq, Jaffar A.
    IJID REGIONS, 2024, 10 : 31 - 34
  • [30] Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA
    Klein, Sabrina
    Boutin, Sebastien
    Kocer, Kaan
    Fiedler, Mascha O.
    Storzinger, Dominic
    Weigand, Markus A.
    Tan, Benjamin
    Richter, Daniel
    Rupp, Christian
    Mieth, Markus
    Mehrabi, Arianeb
    Hackert, Thilo
    Zimmermann, Stefan
    Heeg, Klaus
    Nurjadi, Dennis
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (05) : 905 - 908
12345